//Краткое руководство по ведению пациентов с онкологическими заболеваниями мочеполовой системы


Bekema H.J. et al. Systematic review of adrenalectomy and lymph node dissection in locally advanced renal cell carcinoma. Eur Urol. 2013;64:799.

Capitanio U. et al. Lymph node dissection in renal cell carcinoma. Eur Urol. 2011;60:1212.

Kim S.T.H. et al. The relationship of lymph node dissection with recurrence and survival for patients treated with nephrectomy for high-risk renal cell carcinoma. J Urol. 2012;187:e233.

Blom J.H. et al. Radical nephrectomy with and without lymph-node dissection: final results of European Organization for Research and Treatment of Cancer (EORTC) randomized phase 3 trial 30881. Eur Urol. 2009;55:28.

May M. et al. Pre-operative renal arterial embolisation does not provide survival benefit in patients with radical nephrectomy for renal cell carcinoma. Br J Radiol. 2009;82:724.

Maxwell N.J. et al. Renal artery embolisation in the palliative treatment of renal carcinoma. Br J Radiol. 2007;80:96.

Choi J.E. et al. Comparison of perioperative outcomes between robotic and laparoscopic partial nephrectomy: a systematic review and meta-analysis. Eur Urol. 2015;67:891.

Tabayoyong W. et al. Variation in Surgical Margin Status by Surgical Approach among Patients Undergoing Partial Nephrectomy for Small Renal Masses. J Urol. 2015;194:1548.

Shah P.H. et al. Positive Surgical Margins Increase Risk of Recurrence after Partial Nephrectomy for High Risk Renal Tumors. J Urol. 2016;196:327.

Kim S.P. et al. Treatment of Patients with Positive Margins after Partial Nephrectomy. J Urol. 2016;196:301.

Guillotreau J. et al. Robotic partial nephrectomy versus laparoscopic cryoablation for the small renal mass. Eur Urol. 2012;61:899.

Haber G.P. et al. Tumour in solitary kidney: laparoscopic partial nephrectomy vs laparoscopic cryoablation. BJU Int. 2012;109:118.

Klatte T. et al. Perioperative, oncologic, and functional outcomes of laparoscopic

//Краткое руководство по ведению пациентов с онкологическими заболеваниями мочеполовой системы


renal cryoablation and open partial nephrectomy: a matched pair analysis. J Endourol. 2011;25:991.

Thompson R.H. et al. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses. Eur Urol. 2015;67:252.

Pan X.W. et al. Radiofrequency ablation versus partial nephrectomy for treatment of renal masses: A systematic review and meta-analysis. Kaohsiung J Med Sci. 2015;31:649.

Arnoux V. et al. Perioperative outcomes and mid-term results of radiofrequency ablation and partial nephrectomy in indications of renal tumor treatment and imperative nephron-sparing procedure. Prog Urol. 2013;23:99.

Motzer R.J., Bacik J., Murphy B.A. et al. Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma. J. Clin. Oncol. 2002;20(1):289–296.

Heng D.Y., Xie W., Regan M.M. et al. External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study. Lancet Oncol. 2013;14:141–148.

Heng D.Y., Wells J.C., Rini B.I., Beuselinck B., Lee J.L., Knox J.J. et al. Cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium. Eur Urol. 2014;66:704–710.

Bex A. et al. Immediate versus deferred cytoreductive nephrectomy (CN) in patients with synchronous metastatic renal cell carcinoma (mRCC) receiving sunitinib (EORTC 30073 SURTIME). Ann. Oncol. 2017;28(suppl. 5):md440.030.

Méjean A., Ravaud A., Thezenas S. et al. Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma. N Engl J Med. 2018 Jun 3. doi: 10.1056/NEJMoa1803675.

Graham J., Wells C., Donskov F. et al. Cytoreductive nephrectomy in metastatic papillary renal cell carcinoma: results from the International Metastatic Renal